JI Juan, CHEN Xuemei. Effect of nursing case management on early clinical efficacy for acute ischemic stroke patients with thrombolytic therapy[J]. Journal of Clinical Medicine in Practice, 2019, 23(15): 31-33, 37. DOI: 10.7619/jcmp.201915008
Citation: JI Juan, CHEN Xuemei. Effect of nursing case management on early clinical efficacy for acute ischemic stroke patients with thrombolytic therapy[J]. Journal of Clinical Medicine in Practice, 2019, 23(15): 31-33, 37. DOI: 10.7619/jcmp.201915008

Effect of nursing case management on early clinical efficacy for acute ischemic stroke patients with thrombolytic therapy

More Information
  • Received Date: April 19, 2019
  • Revised Date: June 27, 2019
  • Available Online: February 23, 2021
  • Published Date: August 14, 2019
  •   Objective  To explore the effect of nursing case management on early clinical efficacy for acute stroke patients with thrombolytic therapy.
      Methods  A total of 80 patients with acute ischemic stroke who received thrombolytic therapy were randomly divided into two groups. Control group received routine nursing and experimental group received case management nursing. The time from admission to thrombolytic therapy was recorded. National Institutes of Health Stroke Scale (NIHSS) scores before and after 24 h of thrombolytic therapy in two groups were compared.
      Results  The time from admission to thrombolysis was (34.22±4.83) min in the experimental group, which was significantly less than (70.56±7.68) min in the control group(P < 0.05). There was no significant difference in NIHSS score between the two groups before thrombolytic therapy(P > 0.05). At 24 h after treatment, the NIHSS score in the experimental group was significantly lower than treatment before and the control group (P < 0.05), but the control group showed no significant improvement compared to treatment before (P > 0.05).
      Conclusion  Nursing case management is helpful for improving the early clinical effect of thrombolytic therapy in patients with acute ischemic stroke.
  • [1]
    Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010[J]. Lancet, 2012, 380(9859): 2095-2128. doi: 10.1016/S0140-6736(12)61728-0
    [2]
    Krishnamurthi R V, Moran A E, Feigin V L, et al. Stroke prevalence, mortality and disability-adjusted life years in adults aged 20-64 years in 1990-2013: data from the global burden of disease 2013 study[J]. Neuroepidemiology, 2015, 45(3): 190-202. doi: 10.1159/000441098
    [3]
    Zhou M G, Wang H D, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the global burden of disease study 2013[J]. Lancet, 2016, 387(10015): 251-272. doi: 10.1016/S0140-6736(15)00551-6
    [4]
    Liu M, Wu B, Wang W Z, et al. Stroke in China: epidemiology, prevention, and management strategies[J]. Lancet Neurol, 2007, 6(5): 456-464. doi: 10.1016/S1474-4422(07)70004-2
    [5]
    郭伟, 李斗, 彭鹏. 急性缺血性脑卒中急诊急救中国专家共识(2018)[J]. 临床急诊杂志, 2018, 19(6): 351-359. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC201806001.htm
    [6]
    Chapman S N, Mehndiratta P, Johansen M C, et al. Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke[J]. Vasc Health Risk Manag, 2014, 10: 75-87. http://pubmedcentralcanada.ca/pmcc/articles/pmid/24591838
    [7]
    Lukersmith S, Millington M, Salvador-Carulla L. What is case management?A scoping and mapping review[J]. Int J Integr Care, 2016, 16(4): 2-2. doi: 10.5334/ijic.2477
    [8]
    韩英, 林华, 陈少琴, 等. 个案管理模式在脑卒中后功能障碍患者康复护理中的应用[J]. 海南医学, 2015, 26(10): 1559-1560. doi: 10.3969/j.issn.1003-6350.2015.10.0559
    [9]
    林立文, 林岚, 刘真秀. 个案管理在脑卒中患者中的应用[J]. 长春中医药大学学报, 2018, 34(5): 945-948. https://www.cnki.com.cn/Article/CJFDTOTAL-CZXX201805039.htm
    [10]
    Cochrane J W. 回顾性研究指出对心力衰竭患者电话随访能有效减少死亡[J]. 英国医学杂志中文版, 2012, 15(6): 332-332.
    [11]
    李燕, 陈晨, 郭亮梅. 责任制护理小组管理模式在神经内科的实施效果[J]. 解放军护理杂志, 2010, 27(19): 1503-1504. doi: 10.3969/j.issn.1008-9993.2010.19.038
    [12]
    Baker C M, Miller I, Sitterding M, et al. Acute stroke patients comparing outcomes with and without case management[J]. Nurs Case Manag, 1998, 3(5): 196-203. http://www.ncbi.nlm.nih.gov/pubmed/9832763
    [13]
    Jauch E C, Saver J L, Adams H P Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association[J]. Stroke, 2013, 44(3): 870-947. doi: 10.1161/STR.0b013e318284056a
    [14]
    Rostanski S K, Shahn Z, Elkind M S V, et al. Door-to-needle delays in minor stroke: A causal inference approach[J]. Stroke, 2017, 48(7): 1980-1982. doi: 10.1161/STROKEAHA.117.017386
    [15]
    Chen W Q, Pan Y S, Zhao X Q, et al. Intravenous thrombolysis in Chinese patients with different subtype of mild stroke: thrombolysis in patients with mild stroke[J]. Sci Rep, 2017, 7(1): 2299. doi: 10.1038/s41598-017-02579-2
    [16]
    Logallo N, Kvistad C E, Naess H, et al. Mild stroke: safety and outcome in patients receiving thrombolysis[J]. Acta Neurol Scand, 2014, 129: 37-40. doi: 10.1111/ane.12235
    [17]
    余飞, 王维清. 阿替普酶对高龄急性脑梗死静脉溶栓早期疗效及护理要点[J]. 全科医学临床与教育, 2018, 16(3): 350-352. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYL201803038.htm
    [18]
    李军. 重组组织型纤溶酶原激活剂(rt-PA)静脉溶栓治疗急性脑梗死的疗效[J]. 湖南师范大学学报: 医学版, 2018, 15(4): 187-189. doi: 10.3969/j.issn.1673-016X.2018.04.059
    [19]
    Fonarow G C, Zhao X, Smith E E, et al. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative[J]. JAMA, 2014, 311(16): 1632-1640. doi: 10.1001/jama.2014.3203
    [20]
    甘莉, 林侑华, 杨蓉. 台湾地区护理个案管理的发展及现状[J]. 护理研究, 2014, 28(36): 4491-4493. https://www.cnki.com.cn/Article/CJFDTOTAL-SXHZ201436006.htm
    [21]
    薛美琴, 张玲娟. 个案管理模式在我国的应用及思考[J]. 中华护理杂志, 2014, 49(3): 367-371. doi: 10.3761/j.issn.0254-1769.2014.03.028
    [22]
    洪音, 屠丽君, 麻丽萍, 等. 美国个案护理管理模式[J]. 现代医院, 2008, 8(4): 155-156. doi: 10.3969/j.issn.1671-332X.2008.04.082
    [23]
    Fukada M. Nursing competency: definition, structure and development[J]. Yonago Acta Med, 2018, 61(1): 1-7. doi: 10.33160/yam.2018.03.001
    [24]
    刘晓青, 金爱萍, 董琼, 等. 脑卒中病人个案管理的研究及应用进展[J]. 护理研究, 2018, 32(3): 336-339. doi: 10.3969/j.issn.1009-6493.2018.03.002
    [25]
    张寸, 刘晓青, 刘贤亮, 等. 基于个案管理的专人化随访指导对老年脑卒中患者功能结局和治疗依从性的影响[J]. 中华现代护理杂志, 2016, 22(29): 4151-4155. doi: 10.3760/cma.j.issn.1674-2907.2016.29.002
    [26]
    Stachowiak M E, Bugel M J. The clinical nurse leader and the case manager[J]. AJN Am J Nurs, 2013, 113(1): 59-63. doi: 10.1097/01.NAJ.0000425754.43827.14
  • Related Articles

    [1]SHAN Qingting, DU Huaping, LU Man, XIE Li, XU Yuan. Nomogram prediction model for repeated fluctuationof symptoms within 24 hours of intravenous thrombolysis with recombinant tissue plasminogen activator in patients with ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2022, 26(12): 23-28. DOI: 10.7619/jcmp.20220023
    [2]ZHOU Yong, CHEN Rui, ZHI Zhongwen, ZHAO Liandong. Effect observation of diterpene ginkgolides meglumine injection in improvement of neurological function in patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2020, 24(19): 90-92,96. DOI: 10.7619/jcmp.202019026
    [3]ZHANG Ailian, CHEN Xia, ZENG Lu, HUANG Libo, WANG Jianlin, HUANG Chen. Effect of low-dose recombinant tissue plasminogen activator on the prognosis in patients with cardiogenic cerebral embolism[J]. Journal of Clinical Medicine in Practice, 2020, 24(17): 69-72. DOI: 10.7619/jcmp.202017018
    [4]WANG Yichao, ZHANG Yan. Effect of endovascular interventional therapy combined with recombinant tissue plasminogen activator on arterial thrombolysis in patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2020, 24(3): 16-18. DOI: 10.7619/jcmp.202003005
    [5]LONG Yongchun, TANG Xing, TIAN Xiaoyan, ZHAO Jing. Influence of intravenous thrombolysis with mouse nerve growth factor for injection and recombinant tissue-type plasminogen activator on neurological function of patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2019, 23(11): 7-10. DOI: 10.7619/jcmp.201911002
    [6]ZHOU Fan, HUANG Yunfeng. Value of soluble urokinase type plasminogen activator receptor combined with procalcitonin detection in early diagnosis and prognosis of ventilator-associated pneumonia[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 64-67. DOI: 10.7619/jcmp.201907017
    [7]WU Beibei, CHEN Xu. Efficacy and safety of recombinant tissue plasminogen activator in intravenous thrombolysis for early acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2019, (5): 42-45. DOI: 10.7619/jcmp.201905011
    [8]LI Yan, CHEN Meihua, BAI Yu, HE Dan. Nursing of intravenous thrombolysis patients with cerebral infarction caused by middle cerebral artery occlusion of different sites[J]. Journal of Clinical Medicine in Practice, 2017, (20): 7-10. DOI: 10.7619/jcmp.201720003
    [9]SHEN Yongling, ZHU Haibao, LI Yong, SANG Xiaoyi, ZHANG Guanwen, QI Limin. Clinical comparative study on intravenous low dose recombinant tissue plasminogen activator in the treatment of transient ischemic attack[J]. Journal of Clinical Medicine in Practice, 2017, (19): 34-37. DOI: 10.7619/jcmp.201719010
    [10]JIANG Ai-gui, LU Hui-yu, NI Song-shi, SUN Hua, JIANG Sheng-yang. Level of Tissue Plasminogen Activator Expression After Acute Pulmonary Thromboembolism in Rabbit[J]. Journal of Clinical Medicine in Practice, 2007, (9): 31-34,39. DOI: 10.3969/j.issn.1672-2353.2007.09.009
  • Cited by

    Periodical cited type(24)

    1. 张媛昊. 分析吸入用布地奈德混悬液联合硫酸特布他林雾化吸入用溶液治疗小儿毛细支气管炎的临床疗效及对血清IL-4、IL-6、IL-8、TNF-α、IFN-γ的影响. 黑龙江医药. 2025(01): 33-37 .
    2. 木国法,李旭,龚应玲. 白细胞介素-4、瘦素、趋化素与肥胖型哮喘患儿病情程度的关系及预测哮喘控制的价值. 实用临床医药杂志. 2025(03): 108-113 . 本站查看
    3. 尹莉娜. 小儿推拿疗法联合药物雾化治疗小儿慢性持续期支气管哮喘护理研究. 航空航天医学杂志. 2024(02): 233-235 .
    4. 薛绍芬,田英,陈雅. 糜蛋白酶联合特布他林雾化治疗支气管哮喘的临床效果. 实用临床医学. 2024(02): 14-18 .
    5. 何茸茸,徐莉,刘晶晶. 特布他林联合布地奈德雾化吸入对小儿哮喘治疗的效果分析. 智慧健康. 2024(11): 77-79 .
    6. 武文会,刘琳,耿贝贝. 氨茶碱联合特布他林与沙丁胺醇对老年支气管哮喘的治疗作用. 华夏医学. 2024(04): 185-190 .
    7. 李爱平,刘敏. 布地奈德联合特布他林雾化吸入治疗小儿支气管炎的疗效及作用机制分析. 临床研究. 2024(09): 58-61 .
    8. 巫小燕,邓暄辉. 特布他林联合布地奈德治疗支气管肺炎患儿的效果及对临床症状的影响. 医学信息. 2024(20): 131-134 .
    9. 谷志勇,刘一波. 血清CKLF-1、COX-2水平对支气管哮喘患儿临床分型的价值. 国际检验医学杂志. 2023(04): 446-449 .
    10. 常婷,杜秋燕. 特布他林结合布地奈德雾化吸入治疗小儿哮喘的临床效果. 临床医学研究与实践. 2023(12): 47-50 .
    11. 王萍,罗慧,宋春莉,陈立波. 不同剂量布地奈德对儿童支气管哮喘疗效和炎症抑制的影响. 中南医学科学杂志. 2023(05): 737-740 .
    12. 闫雪. 氨溴索联合特布他林、布地奈德治疗小儿支气管肺炎的临床效果. 妇儿健康导刊. 2023(01): 132-134 .
    13. 黄莹,郑秀琴,陈岚. 特步他林并布地奈德治疗对急性支气管哮喘患者IL-5、IL-10及TNF-α的影响. 分子诊断与治疗杂志. 2022(01): 161-164 .
    14. 赵日婵,梁方华,严有敏. 布地奈德与硫酸特布他林雾化吸入对小儿哮喘患儿血清变态反应的影响. 中国医药科学. 2022(04): 88-91 .
    15. 凌媛,陈列. 特布他林联合孟鲁司特钠治疗支气管哮喘患者的临床疗效. 临床合理用药杂志. 2022(09): 36-38 .
    16. 张洪琼,闫天凌,钱军. 特布他林、孟鲁司特钠联合治疗支气管哮喘的临床效果及呼吸力学指标观察. 解放军医药杂志. 2022(06): 96-99 .
    17. 罗媛珍,戴建华. 喘可治注射液联合布地奈德混悬液雾化治疗小儿支气管哮喘的临床观察. 现代诊断与治疗. 2022(08): 1145-1147 .
    18. 余准,黄锴川,林凯. 特布他林与异丙托溴铵雾化治疗支气管哮喘中重度急性发作的疗效及对肺功能的影响. 中国处方药. 2022(07): 114-116 .
    19. 车蓬丽,崔文兰. 孟鲁司特钠联合沙美特罗替卡松治疗小儿支气管哮喘的临床效果及对免疫功能、STAT1、IRF1的影响. 临床医学研究与实践. 2022(28): 77-80 .
    20. 齐莎莎,张国伟,孟凡威,付晓梅,张宏. 细菌溶解产物胶囊联合扎鲁司特、布地奈德气雾剂治疗支气管哮喘缓解期患儿的效果观察. 医学理论与实践. 2022(23): 4057-4059 .
    21. 乐丽君. 穴位贴敷联合雾化吸入治疗小儿喘息临床分析. 湖北理工学院学报. 2021(05): 55-59 .
    22. 刁秀伟,陈勇. 布地奈德联合盐酸氨溴索雾化吸入治疗小儿支气管肺炎的临床疗效. 江西医药. 2021(09): 1465-1467 .
    23. 丰红梅,赵梦. 布地奈德雾化吸入联合家庭教育对儿童哮喘的临床疗效观察. 中国妇幼保健. 2021(23): 5454-5458 .
    24. 赵芳,刘振国,常瑛,葛莉,李芳. 肺热清颗粒联用糖皮质激素对小儿支气管哮喘氧化/抗氧化失衡的影响. 湖南师范大学学报(医学版). 2021(06): 171-174 .

    Other cited types(0)

Catalog

    Article views (285) PDF downloads (14) Cited by(24)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return